Financial Results Summary

Consolidated Performance (All figures in ₹ millions)

Year Ended March 31, 2026:

  • Total Income: ₹3,945.66 (FY25: ₹3,312.87)
  • Profit Before Tax: ₹511.80 (FY25: ₹337.16)
  • Net Profit: ₹379.37 (FY25: ₹243.05)
  • Basic EPS: ₹3.43 (FY25: ₹1.75)
  • Diluted EPS: ₹3.09

Quarter Ended March 31, 2026:

  • Total Income: ₹1,189.96 (Q4 FY25: ₹1,077.56)
  • Profit Before Tax: ₹154.27 (Q4 FY25: ₹100.34)
  • Net Profit: ₹109.04 (Q4 FY25: ₹77.54)
  • Basic EPS: ₹0.99 (Q4 FY25: ₹0.70)
  • Diluted EPS: ₹0.89

Standalone Performance (All figures in ₹ millions)

Year Ended March 31, 2026:

  • Total Income: ₹3,343.34 (FY25: ₹2,775.29)
  • Profit Before Tax: ₹512.43 (FY25: ₹364.72)
  • Net Profit: ₹381.48 (FY25: ₹269.69)
  • Basic EPS: ₹3.45 (FY25: ₹1.99)
  • Diluted EPS: ₹3.10

Quarter Ended March 31, 2026:

  • Total Income: ₹1,046.21 (Q4 FY25: ₹856.74)
  • Profit Before Tax: ₹181.98 (Q4 FY25: ₹89.17)
  • Net Profit: ₹136.33 (Q4 FY25: ₹66.41)
  • Basic EPS: ₹1.23 (Q4 FY25: ₹0.60)
  • Diluted EPS: ₹1.11

Board Meeting Details

  • Date: Tuesday, June 30, 2026
  • Time: Commenced at 02:46 PM, concluded at 04:28 PM
  • Location: Registered Office at 404, Global Chamber, Adarsh Nagar, Link Road, Andheri (W), Mumbai - 400053

Key Board Decisions

1. Approved audited Standalone and Consolidated Financial Results for quarter and financial year ended March 31, 2026

2. Approved re-appointment of M/S KPMSS & Associates as Cost Auditor for FY 2026-27 with remuneration subject to shareholder ratification at ensuing 33rd AGM

3. Approved re-appointment of M/S Bhuwania & Agrawal Associates as Internal Auditors for FY 2026-27

Subsequent Events Disclosed

Merger Completion

  • Hexagon Nutrition (Exports) Private Limited merged with Hexagon Nutrition Limited
  • NCLT approval received on January 14, 2026 (Order No: C.P.(CAA)/225(MB)2025 C.A.(CAA)/141(MB)2025)
  • Appointed date: April 1, 2025
  • Accounted using Pooling of Interests Method under Ind AS 103
  • Comparative figures restated accordingly

CCPS Conversion

  • Compulsorily Convertible Preference Shares converted to equity shares on April 20, 2026
  • Paid-up equity share capital increased post-conversion
  • No impact on FY26 financial numbers except diluted EPS disclosure

IPO Completion

  • 100% Offer for Sale of 3,08,59,704 equity shares of face value ₹1 each
  • Offer price: ₹45 per share, aggregating ₹138.87 crores
  • Listed on NSE and BSE on June 12, 2026
  • Company received no proceeds from OFS
  • All share issue expenses recovered from selling shareholders

Auditor Emphasis Matters

Auditors highlighted four key matters in their report:

1. Merger of Hexagon Nutrition (Exports) Private Limited with holding company

2. Conversion of CCPS into equity shares subsequent to reporting date

3. Listing of equity shares on stock exchange subsequent to reporting date

4. Material uncertainty regarding going concern of two foreign subsidiaries (Hexagon Nutrition Proprietary Ltd South Africa and Hexagon Nutrition LLC Uzbekistan)

Foreign Subsidiaries Status

  • Two subsidiaries (HNPTY South Africa and HNLLC Uzbekistan) in net liability position of ₹(121.91) million as of March 31, 2026
  • Despite historical losses, registered net profits of ₹39.50 million during FY26
  • Holding company committed to provide unconditional financial support
  • Financial statements prepared on going concern basis

Segment Information

  • Company operates in single business segment: "manufacturing of nutritional products"
  • In accordance with Ind AS 108 - Operating Segments

Subsidiaries Included in Consolidation

1. Hexagon Nutrition (International) Private Limited - 100% Wholly owned subsidiary

2. Hexagon Nutrition Healthcare Private Limited - 100% Wholly owned subsidiary

3. Hexagon Nutrition Proprietary Ltd - South Africa - 100% Wholly owned subsidiary

4. Hexagon Nutrition LLC - Uzbekistan - 100% Wholly owned subsidiary

5. Hexagon China Nutrition Ltd - Hong Kong - 100% Wholly owned subsidiary

Auditor Information

  • Statutory Auditor: S K Patodia & Associates LLP (Firm Registration No: 112723W/W100962)
  • Cost Auditor: KPMSS & Associates (Firm Reg. No: 005229)
  • Internal Auditor: Bhuwania & Agrawal Associates
  • All auditors issued unmodified opinions

Financial Position (Consolidated)

As at March 31, 2026:

  • Total Assets: ₹3,184.03 million (FY25: ₹2,613.59 million)
  • Equity Share Capital: ₹110.63 million
  • Other Equity: ₹2,222.30 million (FY25: ₹1,831.18 million)
  • Inventories: ₹839.01 million (FY25: ₹612.05 million)
  • Trade Receivables: ₹817.18 million (FY25: ₹598.24 million)
  • Cash and Cash Equivalents: ₹157.74 million (FY25: ₹152.23 million)

Cash Flow Analysis (Consolidated)

Year Ended March 31, 2026:

  • Net Cash from Operating Activities: ₹62.31 million (FY25: ₹384.74 million)
  • Net Cash used in Investing Activities: ₹(56.91) million (FY25: ₹(223.43) million)
  • Net Cash used in Financing Activities: ₹(3.25) million (FY25: ₹(192.57) million)
  • Net Decrease in Cash: ₹(4.29) million (FY25: ₹(31.26) million)

Additional Information

  • Previous year figures regrouped/reclassified where necessary
  • For FY25, diluted EPS equal to basic EPS as it was anti-dilutive
  • Figures for quarters ended December 31, 2025 and March 31, 2025 not audited/reviewed as quarterly reporting requirement commenced from listing date

#Tags: #HexagonNutrition #FY2026Results #SEBIDisclosure #RegulatoryCompliance #FinancialResults #IPO #Neutral